Mechanisms of Biosynthetic Formation of Deoxy Sugars

NIH RePORTER · NIH · R01 · $443,011 · view on reporter.nih.gov ↗

Abstract

ABSTRACT The development of new pharmaceuticals and other agents of biomedical value has frequently relied on discoveries made in the field of natural products research. Carbohydrates in particular often represent the key components of these natural products and are critical to their biological activities. Many of these sugars are in turn characterized by unique structural features, the introduction of which typically requires biosynthetic transformations that have never been seen before. Those working in the field of drug discovery often hope to harness these biosynthetic pathways and enzymes in their efforts to identify and engineer new medicines; however, in order to fully realize the potential of synthetic biology, the unprecedented chemistry behind these biological reactions must be understood at a fundamental level. Providing such a foundation is the ultimate goal of our research efforts, and our aim has thus been to enrich the repertoire of tools available to natural product chemists and synthetic biologists in their efforts to develop new pharmaceuticals for the benefit of human health. In this spirit, we have identified several systems for further study in the next funding period. The first specific aim focuses on the mechanism by which four-membered oxetane rings are created from five-membered furanose rings during the biosynthesis of oxetanocin A and albucidin. This aim is a continuation of our previous studies on B12-dependent radical SAM enzymes that catalyze ring contraction reactions. The two enzymes being studied are unique in their class, because nearly all other examples characterized to date catalyze methylation reactions. The second specific aim is a mechanistic investigation of the process by which the bridging oxygen in the furanose ring of cytidine diphosphate is replaced with sulfur during biosynthesis of the Trojan horse antibiotic albomycin δ2. This is a radical SAM enzyme catalyzed reaction reminiscent of radical-initiated sulfur insertion reactions; however, it involves the unprecedented swapping of a ring-bridging oxygen for sulfur rather than the insertion of sulfur into a carbon-hydrogen bond. The third specific aim is a biosynthetic analysis of the dioxane- ring containing aminoglycoside spectinomycin as well as a mechanistic investigation of the dioxane-forming reaction. Spectinomycin is an antibiotic with proven clinical value; however, the biosynthesis of its unusual tricyclic structure, which involves radical-mediated chemistry, is still not understood. These research aims have been carefully designed to include not only the study of new and interesting biochemical reactions but systems that are already known to display properties of medicinal value and may thus be further capitalized on. Consequently, the proposed research is intended to reveal new insights into the biosynthesis of atypical and bioactive carbohydrates in order to strengthen the foundation for future biomedical and biotechnological research at ...

Key facts

NIH application ID
10209563
Project number
2R01GM035906-37
Recipient
UNIVERSITY OF TEXAS AT AUSTIN
Principal Investigator
HUNG-WEN LIU
Activity code
R01
Funding institute
NIH
Fiscal year
2021
Award amount
$443,011
Award type
2
Project period
1986-01-01 → 2025-05-31